Pharmacological studies on a new dihydrothienopyridine calcium antagonist, S-312-d: Therapeutic effects of s-312-d on cerebral metabolic impairment in stroke-prone spontaneously hypertensive rats
1999 ◽
Vol 80
(3)
◽
pp. 199-208
◽
1998 ◽
Vol 30
(3)
◽
pp. 379-386
◽
1991 ◽
Vol 57
(4)
◽
pp. 517-526
1993 ◽
Vol 125
(2)
◽
pp. 578-581
◽
1995 ◽
Vol 26
(2)
◽
pp. 333-337
◽
1994 ◽
Vol 15
(5)
◽
pp. 431-438
◽